Please login to the form below

Not currently logged in

protease inhibitor

This page shows the latest protease inhibitor news and features for those working in and with pharma, biotech and healthcare.

Shionogi’s antiviral COVID-19 treatment meets phase 3 primary endpoint

Shionogi’s antiviral COVID-19 treatment meets phase 3 primary endpoint

Ensitrelvir reduced the time taken to resolve five key symptoms. Shionogi’s ensitrelvir fumaric acid (ensitrelvir) – an investigational protease inhibitor being evaluated as an antiviral treatment for COVID-19 – demonstrated a

Latest news

More from news
Approximately 2 fully matching, plus 83 partially matching documents found.

Latest Intelligence

  • Forging a path in specialty care Forging a path in specialty care

    Adcetris (for Hodgkin Lymphoma), Entyvio (for ulcerative colitis and Crohn's Disease) and future compound Ninlaro (an oral protease inhibitor for relapsed/refractory multiple myeloma) which was approved by the FDA

  • Pharma deals in May 2015 Pharma deals in May 2015

    The agreement covers ACH 3102, ACH 3422 and sovaprevir. The intention is to trial a combination of ACH 3102 with a NS3/4A HCV protease inhibitor plus an NS5B HCV polymerase ... inhibitor. ACH 3102 has been granted fast track designation by the FDA.

  • Deal Watch table for June 2013 Deal Watch table for June 2013

    1, 000. Aragon Pharmaceuticals / J&J. Acquisition. Includes ARN 509 (second generation androgen receptor signalling inhibitor) for castration-resistant prostate cancer (phase II). ... BL8030, second generation protease inhibitor in development for

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts


Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....